ASX - Delayed Quote AUD

Telix Pharmaceuticals Limited (TLX.AX)

13.13 -0.35 (-2.60%)

At close: October 30 at 4:13:31 PM GMT+11

Australian Growth Stocks With Insider Buying For October 2026

Simply Wall St. 17h ago

REG.AX

TLX

LTR.AX
FDA Alignment to Advance ProstACT Global Phase 3 Trial

GlobeNewswire 3mo ago

TLX.AX
-2.60%
TLX
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

GlobeNewswire 4mo ago

TLX.AX
-2.60%
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

PR Newswire 4mo ago

TLX.AX
-2.60%
Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership

Insider Monkey 4mo ago

TLX.AX
-2.60%
TLX
Telix and United Imaging Announce Strategic Theranostics Collaboration

GlobeNewswire 4mo ago

TLX.AX
-2.60%
TLX
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

GlobeNewswire 4mo ago

TLX.AX
-2.60%
TLX
Is Telix (ASX:TLX) Quietly Assembling a Connected Oncology Platform That Reshapes Its Moat?

Simply Wall St. 5mo ago

TLX.AX
-2.60%
TLX
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

GlobeNewswire 5mo ago

TLX.AX
-2.60%
TLX
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

GlobeNewswire 5mo ago

TLX.AX
-2.60%
TLX
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

GlobeNewswire 5mo ago

TLX.AX
-2.60%
EDAP

PROF
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

GlobeNewswire 5mo ago

TLX.AX
-2.60%
TLX

U.S. markets closed

Telix Pharmaceuticals Limited (TLX.AX)

Australian Growth Stocks With Insider Buying For October 2026

FDA Alignment to Advance ProstACT Global Phase 3 Trial

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership

Telix and United Imaging Announce Strategic Theranostics Collaboration

ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

Is Telix (ASX:TLX) Quietly Assembling a Connected Oncology Platform That Reshapes Its Moat?

Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC